Location
New York, NY
Holdings as of
9/30/2023
Date filed
11/14/2023
Form type
13F-HR
Num holdings
88
Total value ($000)
$4,538,793
Net value change ($000)
-145,403 (-3.1%)
New positions
15
Sold out positions
24
Turnover %
24.3%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 8/14/2023 Next filing: 2/14/2024 SEC filing

Snapshot: Change Analysis

Compared to Q2 2023
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
NUVL 75,966 9.0%
BIO 62,351 NEW
CNC 46,081 50.6%
IART 43,034 NEW
SGRY 42,705 NEW
RayzeBio, Inc. 25,733 NEW
NBIX 22,017 19.3%
PODD 20,255 NEW
VTRS 19,173 10.9%
CRBU 16,730 NEW
Top Reduces (Value $000, Stocks/ETFs)
ADY -164,043 -100.0%
Silk Road Medical Inc -36,786 -100.0%
SPRY -32,347 -43.6%
NAMS -30,150 -100.0%
COGT -29,237 -73.4%
APLS -28,541 -100.0%
AMLX -22,653 -100.0%
ATEC -21,390 -100.0%
VTYX -20,238 -100.0%
TERN -16,614 -100.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type